title: Noninvasive tests for diagnosis of Chlamydia trachomatis infection: application of ligase chain reaction to first-catch urine specimens of women.
abstract: Ligase chain reaction (LCR) to diagnose Chlamydia trachomatis infection was evaluated using first-catch urine (FCU) specimens from 4053 women. Results were compared with those of cell culture (TC) isolation from cervix (all) and urethra (2812 women). The reference standard was TC positivity or positive LCR for chlamydial plasmid DNA confirmed by direct fluorescent antibody test or LCR for another chlamydial gene. Compared with cervical culture, LCR was 88.2% sensitive and 100% specific. Adding urethral culture increased TC sensitivity from 67.1% to 74% and reduced LCR sensitivity to 85.9%. The prevalence of chlamydial infection was 5% (142/2812) by the dual culture system and 5.9% (165/2812) by LCR on FCU specimens. LCR on FCU specimens is highly sensitive and specific for diagnosing chlamydial infection. It is more sensitive than TC and may well present public health authorities with a useful noninvasive screening test for chlamydial infection in asymptomatic women.
authors.affiliation: Department of Laboratory Medicine, University of California, San Francisco, USA.
authors.forename: J
authors.initials: J
authors.lastname: Schachter
authors.forename: J
authors.initials: J
authors.lastname: Moncada
authors.forename: R
authors.initials: R
authors.lastname: Whidden
authors.forename: H
authors.initials: H
authors.lastname: Shaw
authors.forename: G
authors.initials: G
authors.lastname: Bolan
authors.forename: J D
authors.initials: JD
authors.lastname: Burczak
authors.forename: H H
authors.initials: HH
authors.lastname: Lee
mesh_terms: D002478:Cells, Cultured; D002584:Cervix Uteri / Q000382:microbiology* / Q000473:pathology; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000453:epidemiology / Q000652:urine; D002692:Chlamydia trachomatis / Q000235:genetics / Q000302:isolation & purification; D046508:Culture Techniques / Q000379:methods; D005260:Female; D019085:Fluorescent Antibody Technique, Direct; D005798:Genes, Bacterial; D006801:Humans; D021141:Nucleic Acid Amplification Techniques; D010957:Plasmids / Q000032:analysis; D015995:Prevalence; D012495:San Francisco / Q000453:epidemiology; D012680:Sensitivity and Specificity; D014521:Urethra / Q000382:microbiology* / Q000473:pathology